Zobrazeno 1 - 10
of 1 019
pro vyhledávání: '"LYMPHANGITIS CARCINOMATOSIS"'
Publikováno v:
Cancer Medicine, Vol 12, Iss 19, Pp 19583-19594 (2023)
Abstract Background The clinicopathological features of MET‐amplified gastric cancer (GC) and real‐world data on the efficacy of MET‐targeted therapies remain unknown. Pulmonary lymphangitis carcinomatosis (PLC) is a peculiar manifestation of G
Externí odkaz:
https://doaj.org/article/f9989ea2b0604b71ac7fc9f6584f7573
Autor:
Alquaydheb, Hisham1 (AUTHOR) drhisham.ns@gmail.com, Alharbi, Abrar2 (AUTHOR), Badran, Ahmed3,4 (AUTHOR), Alshamsan, Bader3,5 (AUTHOR), Algwaiz, Ghada2 (AUTHOR), Elshenawy, Mahmoud A2,6 (AUTHOR), Ajarim, Dahish3 (AUTHOR)
Publikováno v:
Clinical Medicine Insights: Case Reports. 12/6/2023, p1-4. 4p.
Autor:
Zhang, Zhening1 (AUTHOR), Yu, Yiyi2 (AUTHOR), Xie, Tong1 (AUTHOR), Qi, Changsong1 (AUTHOR), Zhang, Xiaotian1 (AUTHOR), Shen, Lin1 (AUTHOR), Peng, Zhi1 (AUTHOR) zhipeng@bjmu.edu.cn
Publikováno v:
Cancer Medicine. Oct2023, Vol. 12 Issue 19, p19583-19594. 12p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Association of Pulmonologist of Tamil Nadu, Vol 6, Iss 2, Pp 72-75 (2023)
Lymphangitis carcinomatosis (LC) is the infiltration and inflammation of lymphatic vessel secondary to the spread of malignancy from a primary site. Most cases result from dissemination of adenocarcinomas. Its presentation may be unilateral or bilate
Externí odkaz:
https://doaj.org/article/64e1a3673c4c4389886aa6541217ae21
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hisham Alquaydheb, Abrar Alharbi, Ahmed Badran, Bader Alshamsan, Ghada Algwaiz, Mahmoud A Elshenawy, Dahish Ajarim
Publikováno v:
Clinical Medicine Insights: Case Reports, Vol 16 (2023)
SARS-CoV-2 infection induces myocardiopathy in 19% of severe cases, with a mortality rate of up to 51%. The mainstay of treatment is supportive care, steroids, and tocilizumab (anti-IL-6). This is a case of a 43-year-old woman diagnosed with hormone-
Externí odkaz:
https://doaj.org/article/9c172cb5089842babda82ce2a6df4b01
Autor:
Singh BS; Department of Dermatology, Venereology and Leprosy, Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Odisha, India., Nayak MK; Department of Dermatology, Venereology and Leprosy, Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Odisha, India., Biswal R; Department of Pathology, Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Odisha, India., Singh S; Department of Pathology, Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Odisha, India., Biswal A; Department of Dermatology, Venereology and Leprosy, Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Odisha, India.
Publikováno v:
Indian journal of dermatology, venereology and leprology [Indian J Dermatol Venereol Leprol] 2024 Apr 16, pp. 1-3. Date of Electronic Publication: 2024 Apr 16.
Autor:
Yadav, Subhash1 (AUTHOR), Kane, Shubhada1 (AUTHOR), Kumar, Rajiv1 (AUTHOR), Rekhi, Bharat1 (AUTHOR), Yadav, Subhash C2 (AUTHOR)
Publikováno v:
Indian Journal of Pathology & Microbiology. Apr-Jun2022, Vol. 65 Issue 2, p422-425. 4p.
Autor:
Gądek, Konrad1 kgadek@gumed.edu.pl, Rutkowski, Jacek2
Publikováno v:
Palliative Medicine in Practice. 2019, Vol. 13 Issue 3, p156-160. 5p.